Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy

Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation

(2020) Gregory K. Behbehani et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes

(2020) Yulia O. Davydova et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Immunophenotypic Features of Myeloid Neoplasms Associated with Chromosome 7 Abnormalities

(2019) Xueyan Chen et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Use of a Blast Dominance–Hematogone Index for the Flow Cytometric Evaluation of Myelodysplastic Syndrome (MDS)

(2019) Jason M Schenkel et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Low-Grade Myelodysplastic Syndromes With Preserved CD34+ B-Cell Precursors (CD34+ Hematogones)

(2019) Zhining Chen et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

The diagnostic and prognostic role of flow cytometry in idiopathic and clonal cytopenia of undetermined significance (ICUS/CCUS): A single‐center analysis of 79 patients

(2019) Konstantinos Dimopoulos et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A-related cancer stem cell biology

(2018) Marie Bill et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes

(2018) Benjamin N. Ostendorf et al.   PLoS One

The current approach to the diagnosis of myelodysplastic syndromes ☆

(2018) Olga K. Weinberg et al.   SEMINARS IN HEMATOLOGY

Application of immunophenotypic analysis in distinguishing chronic myelomonocytic leukemia from reactive monocytosis

(2018) Ru Feng et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level

(2018) Jiahao Chen et al.   NATURE MEDICINE

Leukemic stem cells: identification and clinical application

(2017) Diana Hanekamp et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia

(2016) Bas Kersten et al.   BRITISH JOURNAL OF HAEMATOLOGY

Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome

(2016) Marie Toft-Petersen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations

(2015) Canan Alhan et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia

(2015) W Zeijlemaker et al.   LEUKEMIA

Loss of Blast Heterogeneity in Myelodysplastic Syndrome and Other Chronic Myeloid Neoplasms

(2014) Dragan Jevremovic et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts

(2014) Patricia Font et al.   ANNALS OF HEMATOLOGY

Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

(2014) Petter S. Woll et al.   CANCER CELL

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

(2014) A Porwit et al.   LEUKEMIA

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

(2013) M M Patnaik et al.   LEUKEMIA

Diagnostic Potential of CD34+ Cell Antigen Expression in Myelodysplastic Syndromes

(2012) Dieter De Smet et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations

(2012) B. Will et al.   BLOOD

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

(2012) P. L. Greenberg et al.   BLOOD

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

(2012) M. G. Della Porta et al.   HAEMATOLOGICA

Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome

(2010) Wolfgang Kern et al.   CANCER

Persistent Malignant Stem Cells in del(5q) Myelodysplasia in Remission

(2010) Ramin Tehranchi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Plasmacytoid Dendritic Cells

(2009) Armin G. Jegalian et al.   ADVANCES IN ANATOMIC PATHOLOGY

Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes

(2009) N. Goardon et al.   HAEMATOLOGICA

Multiparameter Flow Cytometric Analysis Reveals Low Percentage of Bone Marrow Hematogones in Myelodysplastic Syndromes

(2008) Sepideh Maftoun-Banankhah et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors

(2008) S Matarraz et al.   LEUKEMIA

Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: Emphasis on a global evaluation and recognition of diagnostic pitfalls

(2007) Dariusz Stachurski et al.   LEUKEMIA RESEARCH